Serotonin Franchise Cost, Revenue & Review 2026
- Investment
- $905K – $1.8M
- Disclosed sales
- partial, no system average
- SBA charge-off
- Under 10 loans (6)
Data from FDD filing + SBA 7(a) records
Analysis by FranchiseVerdict Research · Methodology
Serotonin is a wellness franchise offering hormone optimization, longevity, and anti-aging health programs. Franchisees run the centers, managing clinical staff, patient labs, and treatment plans.
FranchiseVerdict summary · 2026
A Serotonin franchise requires a total initial investment of $905K – $1.8M, including a $59K franchise fee and an ongoing 7.0% royalty[2]. The 2026 FDD on file does not yield a unit-revenue figure we can publish. FranchiseVerdict grade: C (Average), an editorial assessment, not investment advice. Run a live ROI scan →
Sources, dates and evidence
FDD issued: · Data extracted: · Last cited check: · Staleness risk: low - issued within the last 12 months
Evidence: partial✓ Investment (Item 7)✓ Item 19 status✓ Units and owners (Item 20)✗ SBA loan coverage✓ Litigation (Item 3)✓ Financial statements (Item 21)✓ Franchisor identityhow this is scored6 of 6 headline figures on this page cite a page of the filing.
Overview
- Investment
- $905K – $1.8M
- 95th pct Senior Care
- Avg gross sales
- N/A
- Incl. company outlets
- Royalty
- 7.0%
- 77th pct Senior Care
- Units
- 11
- 36th pct Senior Care
- SBA charge-off
- N/A
Quick verdict · Senior Care · color = vs category peers
Green = favorable by >10% vs Senior Care median · No shading = within ±10% · Red = unfavorable by >10% · Source: FDD filings + SBA 7(a)
Data from public FDD filings and SBA records. Not financial advice. Methodology
Bottom line
- COSTTotal investment $905K – $1.8M including a $59K franchise fee, 7.0% ongoing royalty.
- RETURNSItem 19 discloses actual historical Gross Revenue for 4 individual reporting centers (2 affiliate-owned, 2 franchised-owned) open 12+ months as of 12/31/2024; not a systemwide average.
- RISKVerdict C (Average), verdict score 41/100 (higher is better).
- GROWTHPositive: net +2 franchised outlets in the latest year (7 opened, 5 closed); 3 signed but not yet open (Item 20).
- FLAG5 units terminated last reporting year (45.5% of the system). Ask existing franchisees why.
Item 1 · who you're contracting with
The Franchisor
Corporate structure & franchisor financials
- Legal entity
- Serotonin Enterprises LLC
- Parent company
- Longevity Brands, LLC
- FDD Item 1, page 9 of the 2026 FDD
- CEO title
- Chief Executive Officer
- Eric Casaburi
- Incorporated in
- Florida
- HQ
- 7790 Wintergarden Vineland Rd., Suite 100, Windermere, FL 34786
- Auditor
- Divine, Blalock, Martin & Sellari, LLC
- Audited financials
- Franchisor revenue
- $3.8M
- vs $1.3M prior year
Overview
About
- CEO
- Eric Casaburi
- Headquarters
- FL
- Founded
- 2021
- FDD year
- 2026
- States available
- 6
Can you afford it, and what does the money buy?
Entry cost runs 898% above the typical senior care franchise.
Source: FDD 2026 · Items 5–7
FDD Item 7 · 2026 filing
Initial investment breakdown
| Cost component | Low | High |
|---|---|---|
| Initial franchise fee | $59K | $59K |
| Working capital (3–6 mo) | $118K | $354K |
| Equipment, build-out, other | $728K | $1.4M |
| Total initial investment | $905K | $1.8M |
Source: Serotonin 2026 FDD, Items 5 and 7[2]. “Equipment, build-out, other” is computed as total minus disclosed line items above.
Item 7 · what it costs to open + operate
The Vitals
- Total investment
- $905K – $1.8M
- Bottom third — review vs category
- Liquid capital req'd
- $118K – $354K
- Bottom third — review vs category
- Franchise fee
- $59K – $59K
- Bottom third — review vs category
- Royalty
- 7.0%
- typical 6–8%
- Ad fund
- 2.0%
- typical 3–5%
- Total fee load
- 9.0%
- vs 9–13% typical
Ongoing fees · Item 6
| Fee | Amount |
|---|---|
| Royalty | 7.0% of gross sales |
| Marketing / ad fund | 2.0% of gross sales |
| Technology fee | $2K |
| Transfer fee | $30K |
| Renewal fee | $30K |
| Inventory (initial) | $9K – $9K |
| Total fee load | 9.0% of rev |
What do units actually make?
Source: FDD 2026 · Item 19
ROI & LBO modelsSingle-unit · 25-unit portfolio · editable
No Item 19 revenue figure for Serotonin is on file. The return models need a revenue figure to start from, and the operating costs that turn gross sales into a profit are in no FDD. Enter your own and the calculator runs on your assumptions — nothing here is modelled until you do.
Returns model · single-unit ROIC
What would one Serotonin unit return on the cash you put in?
Illustrative category typicals — not sourced to any filing, survey or sample. Replace them with figures from franchisee validation calls before you rely on the output.
Unlevered ROIC · per unit
Your modelled return on total invested capital, before any debt financing.
—
An FDD discloses gross sales, not profit. We hold no sourced figure for annual revenue, COGS, labour, rent / occupancy and other operating costs, and will not substitute an assumed one. Enter your own and the model runs on your assumptions.
These models are for research and scenario planning only. Not investment advice. Actual results depend on your specific location, management, and market conditions. Consult a franchise attorney and accountant before signing any franchise agreement.
Item 19 · Source: 2026 FDD
Financial Performance
Item 19 discloses actual historical Gross Revenue for 4 individual reporting centers (2 affiliate-owned, 2 franchised-owned) open 12+ months as of 12/31/2024; not a systemwide average.
Includes company-owned outlets
- Item 19 type
- historical gross revenue by outlet
- Range (low → high)
- $588K→$1.4MCited, not corroborated — printed on page 70 of the 2026 FDD. Nothing else in our record independently restates or re-derives it.
- Cohort dispersion (min → max)
- Reporting year
- 2024
- Fiscal year the figures cover
- Source filing
- FDD 2026
- Disclosed in the 2026 filing, covering 2024
- Transparency
- 3 / 10
- vs category median 4 / 10 · below
Compared against 79 Senior Care brands
Item 19 · by group
What the filing does disclose
Item 19 of this FDD reports performance in more than one group. We publish no single average for this brand; the groups the filing does disclose are listed below, quoted from its own Item 19 table.
Each row below is quoted from the FDD's own Item 19 table. Gross sales are not profit.
Incl. company outletsItem 19 detail
Item 19 discloses actual historical Gross Revenue for 4 individual reporting centers (2 affiliate-owned, 2 franchised-owned) open 12+ months as of 12/31/2024; not a systemwide average.
affiliate owned
| Segment | Sample | Avg |
|---|---|---|
| Affiliate-Owned Reporting Centers (Windermere, FL) | 1 | $1.9M |
| Affiliate-Owned Reporting Centers (Winter Park, FL) | 1 | $537K |
franchised
| Segment | Sample | Avg |
|---|---|---|
| Franchised-Owned Reporting Centers (Colts Neck, NJ) | 1 | $1.0M |
| Franchised-Owned Reporting Centers (Greenhills, TN) | 1 | $268K |
Operator outlook
What the numbers say
Data-driven interpretation of this brand's financial disclosures, fee structure, and system trajectory.
Fee burden
Total ongoing fee load of 9.0% — above the Senior Care median of 7.0%.
Disclosure
Item 19 reports outlet revenue, but not in a form that yields a per-outlet average we can compare across brands.
Operator retention
Net unit growth of +300.0% over 3 years (7 opened, 5 closed).
Source: FDD Item 19 financial performance representations and publicly filed FDD data. Past performance is not indicative of future results. Verify all figures with the franchisor and current franchisees before making any investment decision.
vs Senior Care medians
How Serotonin Compares
Category median of published Senior Care brands that report the figure; the middle half spans the 25th to 75th percentile and n counts the brands behind it. Medians are used because a few very large systems pull an average far from the typical brand. Revenue is disclosed gross sales, not profit.
Is the system healthy?
Source: FDD 2026 · Item 20
Unit growth
Item 20 · unit dynamics
The Growth Chart
- Total units
- 11
- Opened
- 7
- Last reporting year
- Closed
- 5
- Terminated
- 5
- Franchisor ended the franchise (per Item 20)
- Non-renewed
- 0
- Term expired, not renewed (per Item 20)
- Turnover rate
- 45.5%
- Company-owned
- 3
- Corporate units in the system
- % franchised
- 67%
- vs corporate-owned
- Net growth (3-yr)
- Outlier (see FDD)
- Likely small-sample artifact
Last fiscal year · Item 20 exits and transfers
- Terminated
- 5
- Not renewed
- 0
- Transferred
- 0
- Reacquired
- 0
- Franchisor bought back
- Signed, not yet open
- 3
- 0.27 per open outlet · Item 20 Table 5
- Projected new
- 5
- Franchisor's next-year forecast
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 12 · 6 states reported
The Territory Map
FDD Item 12 reports the state count, but the specific list isn't in our current data. The map will appear once we re-extract from the FDD or enough franchisee contacts are available.
6
states with franchisees (per FDD Item 12)
Fast growth in a small system. Newer franchisors expanding quickly may not yet have the support infrastructure of larger systems.
SBA loan performance
Government records
SBA Loan Data
Aggregated from SBA loan disclosures. This brand has only 6 7(a) loans on file; statistical reliability is limited below 10 loans.
- Total loans
- 6
- Loan volume
- $7.9M
- Median loan
- $1.3M
- 50th percentile
- Charge-off rate
- Under 10 loans (6)
- Insufficient SBA coverage: 6 loans, rate hidden below 10
Historical SBA 7(a) lending data, not predictive of future performance. How SBA charge-off rates are calculated
- Repayment rate (PIF)
- Under 10 loans (6)
- 5-yr charge-off
- Under 10 loans (6)
- Loans approved 2021+
- Active lenders
- 5
- Defaults
- N/A
Explore lender portfolios on Bank Reports or regional data on State Reports.
What could kill this investment?
Source: SBA 7(a) FOIA · FDD Items 3, 21
Risk analysis
FranchiseVerdict rating + FDD Items 3, 4, 8, 16, 21
Risk & Legal
Litigation (Item 3)
Subject: officers or affiliates. The franchisor is not a named party in these cases.
No litigation information required to be disclosed in Item 3.
Bankruptcy (Item 4)
None disclosed
Audited financials (Item 21)
Yes · Divine, Blalock, Martin & Sellari, LLC
Franchisor revenue (Item 21)
Franchisor entity revenue (not unit-level)
Supplier relationship · Items 8 & 16
- Franchisor sells you products: Yes
- Kickbacks from required suppliers: No
- Must buy proprietary products: Yes
- Restricted to system-approved products: Yes
- Can negotiate own supplier terms: No
Score breakdown · what drove the 41 / 100 verdict
- 01MINORNegative net worth -$4,293,318
- 02MINORHigh turnover 33.3%
Severity inferred from the FDD text · not a regulatory classification
What are you signing up for?
Ongoing fees run about 9.0% of sales (royalty + ad fund), before rent and labor.
Source: FDD 2026 · Items 11, 12, 17
FDD Items 12, 15, 17 · continued from Risk & Legal
Contract & Territory Detail
| Initial term | 10 years |
|---|---|
| Renewal term | 5 years |
| Allowed renewalsℹ | 2 |
| Territory type | Protected territory |
| Protected territory | Yes |
| Exclusive territoryℹ | No |
| Territory radius | 3 mi |
| Online sales rightsℹ | Restricted |
| Franchisor can compete | Yes |
| Hire a manager? | Allowed |
| Owner-operator | Optional |
| Non-compete (years)ℹ | 2 years |
| Non-compete (miles)ℹ | 10 mi |
| Right of first refusalℹ | Yes |
| Transfer requires consent | Yes |
| Termination notice | 30 days |
| Mandatory arbitration | Yes |
| Arbitration location | Orange County, Florida |
| Jury trial waiver | Yes |
| Governing law | Florida |
| Litigation count | 0 |
View Item 3 litigation summary
No litigation information required to be disclosed in Item 3.
Items 10, 11
Training & Operations
- Classroom training
- 41 hrs
- On-the-job training
- 22 hrs
- Ongoing training
- Required
- Site selection
- franchisor approval of franchisee-selected site
- Franchisor financing
- Not offered
- Item 10
- POS system
- Zenoti
- Operating tech stack
Items 5 & 11
Franchisor Support
Technology: Zenoti
Frequently asked questions
Frequently Asked Questions
How much does it cost to open a Serotonin franchise?
The total investment to open a Serotonin franchise ranges from $905K – $1.8M, with an initial franchise fee of $59K. This includes real estate, equipment, inventory, and working capital as disclosed in their Franchise Disclosure Document (FDD).
What do Serotonin franchise owners earn?
Item 19 of the Serotonin FDD discloses outlet figures from $588K to $1.4M but no single average across all outlets. These are gross sales figures, not profit; the Revenue section shows what the filing reports and on what basis. Item 20 of the FDD lists current and former franchisees; asking them directly is the standard way to fill this gap.
Who owns Serotonin?
Serotonin is franchised by Serotonin Enterprises LLC. Its parent company is Longevity Brands, LLC. Source: FDD Item 1, 2026 filing.
What is Item 19 in the Serotonin FDD?
The FDD section where a franchisor may disclose financial performance of its outlets. Disclosure is optional and formats vary; figures are typically gross sales, which is revenue before expenses, not profit. FranchiseVerdict extracts these figures directly from the Serotonin FDD and qualifies whose outlets they describe.
What is Serotonin's franchise failure rate?
SBA 7(a) loan charge-off data is not available for Serotonin (fewer than 10 loans on file). Charge-off rates are one way to gauge franchise risk, but not all franchise loans go through the SBA program. We recommend reviewing turnover and closure data in the FDD and speaking with current franchisees.
How many Serotonin franchise locations are there?
As of their most recent FDD filing, Serotonin has 11 total units in the United States, including 8 franchised units and 3 company-owned units. 7 new units were opened in the latest reporting year.
Is Serotonin a good franchise to buy?
FranchiseVerdict rates Serotonin as a C-grade franchise with a verdict score of 41 out of 100 (higher is better). The grade is a deterministic score built from six weighted dimensions — financial health, unit economics, unit growth, scale, legal, and transparency — then calibrated against SBA loan charge-off rates and FDD age. Transparency is one of the six, so a filing that discloses less scores lower on that dimension than one that discloses more. Our rating is based solely on publicly available FDD and government data; we recommend speaking with current franchisees before making any investment decision. This is not investment advice.
Data sourced from public FDD filings and SBA 7(a) FOIA records. Not financial advice.
For franchisors
Are you the franchisor?
If you represent Serotonin, you can request corrections or provide updated information.
Other Senior Care franchises
Compare similar franchise opportunities in the Senior Care category
Data extracted from public FDD filings and SBA 7(a) loan disclosures (FOIA). This information is provided for research purposes only and does not constitute financial, legal, or investment advice. Verify all figures with the franchisor's current Franchise Disclosure Document before making any investment decision.